PRESCRIBERS PATIENTS
PLAY
Cataract Intracameral Injection

Our OMNI intracameral injection is transparent, allowing patients to leave your operating room with clear eyes and uninhibited vision. OMNI injections ship directly to your surgery center or practice at no added cost.

Prescribing OMNI:  New prescribers must complete and submit an OSRX account form. Once received, an OSRX staff member will promptly contact you to discuss pricing and ordering specifics.

Questions? Check out our FAQ. 

Dexamethasone Phosphate 0.1%
Moxifloxacin HCI 0.5%
Sterile Ophthalmic Injection

Potential Contraindications

1 mL

Professional Disclosure: Dr. Khodabakhsh is on the Medical Advisory Board for Ocular Science® (an OSRX affiliate) and has a financial interest in the company.

“These drugs [dexamethasone and moxifloxacin] have been well-studied in terms of safety and efficacy, and have proven to be effective without provoking a steroid response in patients ... While the cost of the injection must be covered by the surgery center, it is comforting to know that this technique is shown in the peer reviewed literature to be the best method of prophylaxis, while at the same time reducing the overall cost to the health care system.”3
- FRANCIS MAH, MD, DIRECTOR OF CORNEA & EXTERNAL DISEASE AT SCRIPPS CLINIC

3: MillennialEYE, 2017 Innovations: "A New Approach to Compounded Ophthalmic Therapies"

Professional Disclosure:  Dr. Mah is on the Medical Advisory Board of Ocular Science® (an OSRX affiliate) and has a financial interest in the company.

OSRX operates in full compliance with Section 503A regarding compounded drugs as defined in the FD&C Act.

*Compounded drugs are not FDA-approved, which means they have not undergone FDA premarket review for safety, effectiveness, and quality. 503A compounding pharmacies are not required to comply with cGMP requirements but can be inspected by FDA. References available upon request.

Click here to view potential contraindications.